Passionate about making a profound impact on patients’ lives

Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic clinical candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world, and research and preclinical programs focused on the discovery of novel antivirals to treat devastating viral diseases, including HBV, hepatitis delta virus (HDV) and herpesviruses.

Focused on Transforming Treatment of Serious Viral Diseases

Assembly Bio’s team aspires to advance treatment options for patients through the discovery and development of novel antivirals. We aim to deliver finite and curative therapies for HBV, one of the world’s most prevalent and devastating infectious diseases, and to progress differentiated research and preclinical programs directed at serious viral diseases.

Explore programs


Board of Directors

William Ringo

Chairman of the Board, Non-Executive

orange arrow
Anthony Altig

Director

orange arrow
Tomas Cihlar, PhD

Director

orange arrow
Gina Consylman

Director

orange arrow
Rob Cook

Director

orange arrow
Sir Michael Houghton, PhD

Director

orange arrow
Lisa Johnson-Pratt, MD

Director

orange arrow
Sue Mahony, PhD

Director

orange arrow
John McHutchison AO, MD

Director

orange arrow
Jason Okazaki

Chief Executive Officer & President, Director

orange arrow

Scientific Advisory Board

Antonio Bertoletti, MD

orange arrow
Edward J. Gane, MBCHB, MD, FRACP, MNZM

orange arrow
Patrick Kennedy, MB BCh BAO BMedSci FR CP MD

orange arrow
Sir Michael Houghton, PhD

orange arrow
Alex Thompson, MBBS, PhD, FRACP

orange arrow
Stephan Urban, PhD

orange arrow
Adam Zlotnick, PhD

orange arrow
Fabien Zoulim, MD, PhD
 

orange arrow

Contact Us

CORPORATE HEADQUARTERS
Two Tower Place
7th floor
South San Francisco, CA 94080
Get Directions

FOR GENERAL INFORMATION,
PLEASE CONTACT:

833.509.4583
info@assemblybio.com

FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:

BD@assemblybio.com